Background: Sulfated chitosan (ChS) is a chemically modified polysaccharide derived from chitin that mimics heparan sulfate (HS) structures and has emerged as a promising antimicrobial biomaterial. Piscirickettsia salmonis, the etiological agent of Salmonid Rickettsial Septicemia (SRS), represents the main driver of antibiotic use in Chilean aquaculture. Objective: In this study, the in vitro antibacterial activity of ChS against P. salmonis was evaluated. Methods: Elemental characterization by SEM-EDS and FTIR analysis confirmed successful sulfation of the polymer, with a degree of sulfation ranging from 0.92 to 0.95. Additionally, X-ray diffraction (XRD) analysis revealed a reduction in polymer crystallinity, indicating a transition toward a more amorphous structure associated with increased molecular flexibility and functional group accessibility. Results: Antibacterial assays revealed a minimum inhibitory concentration (MIC) of 1500 µg/mL and a minimum bactericidal concentration (MBC ≥ 1500 µg/mL). LIVE/DEAD™ fluorescence imaging showed the formation of bacterial aggregates with increasing size, frequency, and red fluorescence compared to controls over the exposure to ChS, indicating progressive membrane damage. This was supported by a reduction (p < 0.05) in the Green/Red fluorescence ratio of 37–46% between 5 h and 96 h of exposure, corresponding to alteration of the cell membrane. Scanning electron microscopy revealed pronounced morphological alterations by ChS, including surface disruption and loss of cellular integrity. This was more severe compared to commercial chitosan (ChC). Also, ChS reduced (p < 0.05) biofilm formation (>50% at day 6 and 34.8% at day 8). Conclusions: These results demonstrated that ChS disrupts the cell membrane and reduces biofilm formation in P. salmonis, thereby affecting viability. This is the first report of the antibacterial effect of ChS, an HS analogue, against P. salmonis.
24 December 2021 in Revista Científica de la Facultad de Ciencias Veterinarias
Mycotoxins, even so government regulates to control their levels in animal balance feeds, they could pose a problem to animal and human consumption health. Therefore, the aim was to determine the levels of total aflatoxins found in the finisher balanced feeds for broilers and pigs, produced by balanced feed factories (BFF) in Venezuela. Eleven BFFs were sampled and evaluated for the presence of aflatoxins: AFB1, AFB2, AFG1 and AFG2, determined using the analytical chemical technique HPLC-FLD. Thirty three feed samples for broilers and 33 for pigs, a total of 66 samples were obtained from BFFs. The presence of aflatoxins was detected in 100 % of the finisher balanced feeds for poultry and pigs. The determined AFB1, AFB2, AFG1 and AFG2 levels in finisher balanced feeds for broilers and pigs, rendered that the aflatoxin with the highest concentration was always AFB1. The averages of total aflatoxins detected from finisher feeds for broilers and pigs were within the maximum allowed limits (20 micrograms (μg) / kilograms (kg) of COVENIN standards (Venezuelan regulations). When compared each aflatoxin level (AFB1, AFB2, AFG1 and AFG2) eight out of eleven BFFs evaluated comply with the standard, but 3 (F1, F2 and F5) BFFs were outside (5 μg/kg). It is pertinent that the companies that produce final food for poultry and pigs carry out additional and frequent evaluations of other mycotoxins (Ocratoxins, fusarium mycotoxins and mycotoxins emerging) present in raw materials, in order to evaluate the risks in the agri-food chain, in the way to implement solutions before or after processesment to ensure public health quality.
Sulfated chitosan (ChS) is a chemically modified chitosan derivative with structural and electrostatic features that mimic selected properties of heparan sulfate (HS) and has emerged as a promising antimicrobial biomaterial. Piscirickettsia salmonis, the etiological agent of salmonid rickettsial septicemia (SRS), is a major bacterial pathogen in salmon aquaculture and a principal driver of antibiotic use in Chile. In this study, we evaluated the in vitro antibacterial and antibiofilm activity of ChS against P. salmonis EM-90 and its interaction with florfenicol (FF) and oxytetracycline (OTC). ChS exhibited a minimum inhibitory concentration (MIC) of 750 µg/mL. Checkerboard assays showed a synergistic interaction between ChS and OTC (ΣFIC = 0.313) and an additive interaction between ChS and FF (ΣFIC = 0.703). Re-inoculation assays indicated predominantly reversible growth inhibition for several inhibitory combinations. LIVE/DEAD™ fluorescence analysis revealed a time-dependent increase in membrane permeabilization following ChS exposure, with a significant 37–63% reduction in the Green/Red fluorescence ratio between 5 and 48 h (p < 0.05). Consistently, scanning electron microscopy (SEM) revealed morphological alterations in ChS-treated bacteria, including irregular and eroded cell surfaces and focal depressions, which were more pronounced than those observed with chitosan without chemical modifications. ChS also significantly inhibited biofilm formation, with reductions exceeding 80% at day 6 and 57% at day 8 (p < 0.05), and altered biofilm architecture, abundance, and spatial distribution at days 6 and 10. Collectively, these findings demonstrate that ChS exerts antibacterial and antibiofilm effects against P. salmonis EM-90 and enhances its in vitro susceptibility to OTC and FF. The membrane alterations induced by ChS provide a plausible mechanistic basis for its antibiotic-potentiating activity, although enhanced intracellular antibiotic uptake was not directly demonstrated. These results support further investigation of ChS as an HS-mimetic biopolymer and complementary antimicrobial strategy for SRS control.
Sulfated chitosan (ChS) is a chemically modified polysaccharide derived from chitin that mimics heparan sulfate (HS) structures and has emerged as a promising antimicrobial biomaterial. Piscirickettsia salmonis (P. salmonis), the etiological agent of Salmonid Rickettsial Septicemia (SRS), represents the main driver of antibiotic use in Chilean aquaculture. In this study, the in vitro antibacterial activity of ChS against P. salmonis was evaluated. Elemental characterization by SEM-EDS confirmed successful sulfation of the polymer, with a degree of sulfation ranging from 0.92 to 0.95. Antibacterial assays revealed a minimum inhibitory concentration (MIC) of 1500 µg/mL and a minimum bactericidal concentration (MBC ≥1500 µg/mL). LIVE/DEAD™ fluorescence imaging showed the formation of bacterial aggregates with increasing size, frequency, and red fluorescence compared to controls over the exposure to ChS, indicating progressive membrane damage. This was supported by a reduction (p < 0.05) in the Green/Red fluorescence ratio of 37–46% between 5h and 96h of exposure, corresponding to alteration of cell membrane. Scanning electron microscopy revealed pronounced morphological alterations by ChS, including surface disruption and loss of cellular integrity. This was more severe compared to native chitosan. Also, ChS reduced (p < 0.05) biofilm formation (>50% at day 6 and 34.8% at day 8). These results demonstrated that ChS disrupts cell membrane and reduces biofilm formation in P. salmonis, which in consequence affects viability. This is currently the first report of the antibacterial effect of ChS as a HS analogue on P. salmonis.